The audit included multiple levels, and confirmed the performance efficacy of the highly qualified staff, the presence of up-to-date equipment, and the availability and compliance with the quality management system.
The GLP Certificate confirms the high level of preclinical studies performed by GEROPHARM.
For the Company, this is an achievement that will contribute to its development in international markets.